Searched for
ANTI OBESITY DRUGS
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...- BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
- RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilitiesRPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- Parliamentary panel recommends mandatory kidney tests for all aged 20 yrs and above every 6 monthsA parliamentary committee proposes mandatory kidney function tests for adults aged twenty and above. High-risk individuals will undergo ann...
- Type 2 diabetes patients on metformin, take note: After 60 years, scientists find this drug has hidden effects on the brainDiabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct br...
- GLP-1 demand stirs up hunger for obesity care talentDemand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: ReportPfizer is close to acquiring Metsera, an anti-obesity drug developer. The deal could be worth $7.3 billion. Pfizer will pay $47.50 per shar...
- ET Graphics: Weight loss drugs Tirzepatide, Semaglutide dominate India, misuse fears riseTirzepatide and semaglutide dominate India's anti-obesity drug market, holding a 75% share. While seen as vital tools by doctors, experts c...
- Cipla eyes entry into India's weight management market amid rising demand and global competitionCipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening it...
- Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other detailsNovo Nordisk has introduced its weight-loss drug, Wegovy, in India. This launch follows Eli Lilly's entry into the market. The company aims...
- India's anti-obesity drug market has grown more than fourfold in the last five yearsIndia's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven by lifestyle di...
- India’s anti-obesity drug market quadruples in five years on lifestyle disease surgeIndia's anti-obesity drug market has surged, growing over fourfold in five years, reaching Rs 576 crore by March 2025. Semaglutide pill Ryb...
- India to make drugs for diabetes, obesity under PLI by 2026, says reportIndia plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a govern...
- New oral diabetes + obesity drug's India sales surge 100%India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenge...
- Anti-obesity drug market gaining traction in IndiaAccording to research firm Pharmarack, the market has tripled in two years after witnessing a sluggish growth till 2021. Over the last five...
- Corona inks agreement with Kitozyme for a fat binder anti-obesity drugBelgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.
- Centre bans anti-obesity drug due to side effectsThe government has banned manufacturing and sale of anti-obesity medicine Sibutramine and its combination drugs sold under various brands d...
- Pharmas gain from your weightYour fat loss is revenue gain for pharma companies. As obesity is fast becoming major concern in developing countries, sales of lifestyle r...
Load More
